Login Form
Registration
Profile Informations
Login Datas
or login
Details
Mounjaro 12.5 mg/dose KwikPen is a prescription medicine developed by Eli Lilly, containing tirzepatide as its active ingredient. It belongs to the class of dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists.
Tirzepatide acts on GIP and GLP-1 receptors, which are involved in the regulation of blood glucose levels and appetite. Mounjaro is indicated for the treatment of insufficiently controlled type 2 diabetes mellitus and, in eligible adults, weight management alongside a reduced-calorie diet and increased physical activity.
The KwikPen is a multi-dose, pre-filled injection device designed to deliver four individual doses. Each dose contains 12.5 mg of tirzepatide in 0.6 ml of solution.
Product Features:
-
Brand: Mounjaro
-
Manufacturer: Eli Lilly
-
Active Ingredient: Tirzepatide
-
Strength: 12.5 mg per dose
-
Pharmaceutical Form: Solution for injection
-
Administration: Subcutaneous injection
-
Device: Multi-dose pre-filled KwikPen
-
Pack Contents: 1 pre-filled pen containing four doses
-
Total Content: 50 mg tirzepatide in 2.4 ml
-
Needles: Not included
Mounjaro should be used strictly according to the prescribing healthcare professional's instructions. The dosage must not be changed without medical advice.

